Cited 0 times in
F-18 FDG PET/CT in NK/T-Cell Lymphoma that Progressed from Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, IH | - |
dc.contributor.author | An, YS | - |
dc.contributor.author | Lee, SJ | - |
dc.contributor.author | Yoon, JK | - |
dc.date.accessioned | 2023-02-13T06:23:00Z | - |
dc.date.available | 2023-02-13T06:23:00Z | - |
dc.date.issued | 2022 | - |
dc.identifier.issn | 1869-3474 | - |
dc.identifier.uri | http://repository.ajou.ac.kr/handle/201003/24468 | - |
dc.description.abstract | Hemophagocytic lymphohistiocytosis (HLH) is a syndrome involving an uncontrolled immune response with variable triggers. HLH is rare but highly fatal, even with proper treatment; therefore, early recognition and diagnosis are crucial for management. Although the role of F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in HLH is poorly defined, it can provide valuable information on disease status and possible triggers. Herein, we report an F-18 FDG PET/CT study on a case of NK/T-cell lymphoma that progressed from Epstein-Barr virus-associated HLH. | - |
dc.language.iso | en | - |
dc.title | F-18 FDG PET/CT in NK/T-Cell Lymphoma that Progressed from Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis | - |
dc.type | Article | - |
dc.identifier.pmid | 35186160 | - |
dc.identifier.url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828808 | - |
dc.subject.keyword | Epstein-Barr virus | - |
dc.subject.keyword | F-18 FDG PET/CT | - |
dc.subject.keyword | Hemophagocytic lymphohistiocytosis | - |
dc.subject.keyword | NK/T-cell lymphoma | - |
dc.contributor.affiliatedAuthor | An, YS | - |
dc.contributor.affiliatedAuthor | Lee, SJ | - |
dc.contributor.affiliatedAuthor | Yoon, JK | - |
dc.type.local | Journal Papers | - |
dc.identifier.doi | 10.1007/s13139-021-00725-3 | - |
dc.citation.title | Nuclear medicine and molecular imaging | - |
dc.citation.volume | 56 | - |
dc.citation.number | 1 | - |
dc.citation.date | 2022 | - |
dc.citation.startPage | 59 | - |
dc.citation.endPage | 62 | - |
dc.identifier.bibliographicCitation | Nuclear medicine and molecular imaging, 56(1). : 59-62, 2022 | - |
dc.identifier.eissn | 1869-3482 | - |
dc.relation.journalid | J018693474 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.